Last updated: May 29, 2026

Application No. 18/042,892

METHOD FOR THE TREATMENT OF A DISEASE USING PIGMENT EPITHELIUM-DERIVED FACTOR (PEDF)

Non-Final OA

Filed

Feb 24, 2023

Priority

Sep 03, 2020 — EU 20194463.4 +2 more

Examiner

BRADLEY, CHRISTINA

Art Unit

1654

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Curebiotech GmbH

OA Round

1 (Non-Final)

Interview Optional

— +33.2% interview lift. Interview already conducted in this application's prosecution history. This examiner has a 63% grant rate with +33.2% interview lift. Since an interview has already been tried, recommend written response with narrowed claims based on precedent claim evolution patterns.

Based on 1028 resolved cases, 2023–2026

Examiner Intelligence

BRADLEY, CHRISTINA View full profile →

Grants 63% of resolved cases

Career Allowance Rate

645 granted / 1028 resolved

+2.7% vs TC avg

Strong +33% interview lift

Without

With

+33.2%

Interview Lift

resolved cases with interview

Typical timeline

2y 8m

Avg Prosecution

44 currently pending

Career history

1073

Total Applications

across all art units

Statute-Specific Performance

§101

1.7%

-38.3% vs TC avg

§103

39.0%

-1.0% vs TC avg

§102

12.2%

-27.8% vs TC avg

§112

11.0%

-29.0% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1028 resolved cases

Prosecution Timeline

Feb 24, 2023

Application Filed

Sep 08, 2025

Non-Final Rejection mailed

Mar 09, 2026

Response Filed

May 05, 2026

Applicant Interview (Telephonic)

May 05, 2026

Examiner Interview Summary

Precedent Cases

Applications granted by this same examiner with similar technology

17/638,930

Patent 12637492

PEPTIDE INHIBITORS OF FOCAL ADHESION KINASE ACTIVITY AND USES THEREOF

4y 2m to grant Granted May 26, 2026

17/916,062

Patent 12637499

Novel Adrenomedullin Analog, Method for Producing the Same, and Pharmaceutical Use Thereof

3y 7m to grant Granted May 26, 2026

18/800,436

Patent 12630601

PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST

1y 9m to grant Granted May 19, 2026

17/310,247

Patent 12624079

PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST

4y 9m to grant Granted May 12, 2026

17/643,527

Patent 12624067

CYCLIC PEPTIDE, CELL SCAFFOLD MATERIAL, CELL SEPARATING MATERIAL, AND MEDIUM

4y 5m to grant Granted May 12, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

63%

Grant Probability

96%

With Interview (+33.2%)

2y 8m (~0m remaining)

Median Time to Grant

Low

PTA Risk

Based on 1028 resolved cases by this examiner. Grant probability derived from career allowance rate.